Strata Critical Medical, Inc.
SRTA Nasdaq
SEC CIK 1779128
Follow Strata Critical Medical
Weekly email: filings, results
Revenue, last quarter
$74.1M
+50.3% vs same quarter last year
Net income
−$7.6M
−113.3% vs same quarter last year
EPS, diluted
−$0.09
−112.9% vs same quarter last year
Operating cash flow
$9.5M
+125.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $197.1M | $41.3M |
| FY24 | $146.8M | −$27.3M |
| FY23 | $225.2M | −$56.1M |
| FY22 | $146.1M | −$27.3M |
| FY21 | $50.5M | −$40.1M |
| FY20 | $23.4M | −$10.2M |
| FY19 | $31.2M | −$10.8M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 20.9% | −11.3% | 21% |
| FY24 | 20.2% | −15.3% | −18.6% |
| FY23 | 18.7% | −30.3% | −24.9% |
| FY22 | 15.2% | −36.6% | −18.7% |
| FY21 | 20.8% | −47.7% | −79.3% |
| FY20 | 9.9% | −44.2% | −43.4% |
| FY19 | 15.1% | −37% | −34.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$58.5M |
| FY24 | −$33.4M |
| FY23 | −$34.5M |
| FY22 | −$37.9M |
| FY21 | −$15.9M |
| FY20 | −$11.2M |
| FY19 | −$10.9M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $0 |
| FY24 | $244K |
| FY23 | $0 |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
- Strata Critical Medical
- Industrials median
Show the numbers
| Year | Strata Critical Medical | Industrials median |
|---|---|---|
| FY25 | 21% | 2.5% |
| FY24 | −18.6% | 3.3% |
| FY23 | −24.9% | 3.7% |
| FY22 | −18.7% | 3.8% |
| FY21 | −79.3% | 3.7% |
| FY20 | −43.4% | 0.2% |
| FY19 | −34.7% | 3.8% |